Mortality in a cohort of HIV-infected adults started on a protease inhibitor-containing therapy: standardization to the general population
Article Abstract:
The mortality rate among HIV patients taking a protease inhibitor is greater than in the general population even if they respond to the drug. This was the conclusion of a study of 1,157 HIV patients, which also documented that the death rate among women was four times higher than among men.
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Health-related quality of life after 1 year of highly active antiretroviral therapy
Article Abstract:
Research has been conducted on the role of highly active antiretroviral therapy in health-related quality of life. The durability of response to antiretroviral therapy and the long-term strategies have been evaluated in identifying factors related to normal levels of h ealth-related quality of life after 1 year of treatment, and the results are reported.
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Factors associated with nonadherence to highly active antiretroviral therapy
Article Abstract:
Factors associated with nonadherence during the maintenance phase of highly active antiretroviral therapy (months 12- 60) in the Anti PROtease Cohort (APROCO) cohort after correcting for the bias due to missing outcome data is identified. Psychosocial interventions and the selections of the Best- tolerated regimens are needed to improve long- term adherence of HIV- infected patients to their lifelong treatment.
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2006
User Contributions:
Comment about this article or add new information about this topic: